CSCIED

期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Clinical Research. 2024; 8: (12) ; 193-195 ; DOI: 10.12208/j.ijcr.20240554.

Analysis of the latest progress in the treatment of chronic obstructive pulmonary disease
慢阻肺治疗最新进展分析

作者: 李欣 *

清镇市犁倭镇卫生院 贵州清镇

*通讯作者: 李欣,单位:清镇市犁倭镇卫生院 贵州清镇;

发布时间: 2024-12-27 总浏览量: 150

摘要

以慢阻肺为主的呼吸道疾病是世界十大致死性疾病之一,其疾病特点为呼吸不畅、肺功能损伤、伴随活动耐力降低,同时慢阻肺无法治愈、容易反复发作。慢阻肺对患者自身和家庭以及社会有严重的负面干扰和影响,因此临床强调对患者实施必要治疗。慢阻肺的传统性治疗方法,主要以稳定期和急性加重期为主要。而随着医学的发展,临床针对该病已经呈现出多元化的治疗趋势,其最新进展包含有三联的吸入制剂治疗、共悬浮给药技术、介入疗法-肺减容术、从免疫机制入手实施疫苗治疗等。本文现就慢阻肺治疗最新进展开展综述,以期为慢阻肺更佳治疗效果提供必要思路和方法。

关键词: 慢阻肺;最新进展;肺部功能;呼吸系统疾病;免疫制剂;三联药剂

Abstract

Respiratory diseases, mainly chronic obstructive pulmonary disease (COPD), are one of the top ten deadly diseases in the world. Their characteristics include poor breathing, impaired lung function, and reduced activity tolerance. At the same time, COPD cannot be cured and is prone to recurrent attacks. Chronic obstructive pulmonary disease (COPD) has serious negative interference and impact on patients themselves, their families, and society. Therefore, clinical emphasis is placed on implementing necessary treatment for patients. The traditional treatment methods for chronic obstructive pulmonary disease mainly focus on stable phase and acute exacerbation phase. With the development of medicine, clinical treatment for this disease has shown a diversified trend, including the latest advances in triple inhalation therapy, co suspension administration technology, interventional therapy lung volume reduction, and vaccine treatment starting from the immune mechanism. This article provides a review of the latest developments in the treatment of chronic obstructive pulmonary disease (COPD), aiming to provide necessary ideas and methods for better treatment outcomes.

Key words: Chronic obstructive pulmonary disease; Latest progress; Pulmonary function; Respiratory system diseases; Immune preparations; Triple agent

参考文献 References

[1] 陈维维. 无创呼吸机治疗慢阻肺合并重症呼吸衰竭进展分析[J]. 特别健康,2024(5):61-62. 

[2] 郭俊宏,肖顺琼. 理痰汤治疗慢阻肺急性加重期的临床研究进展[J]. 世界最新医学信息文摘(连续型电子期刊),2021,21(23):119-120.祖丽皮努尔·阿卜杜萨迪克,帕提曼·吾斯曼,陈祢. 

[3] 李田净. 氧疗结合振动排痰护理干预对慢阻肺患者肺功能、运动耐受性、生活质量的影响[J]. 黑龙江医学,2023, 47(10): 1272-1274. 

[4] 孙盛先. 慢阻肺并Ⅱ型呼吸衰竭患者经有创-无创序贯机械通气治疗的临床效果[J]. 系统医学,2022,7(5):87-90. 

[5] 王晓曦,葛渊源,张景辰,等. 吸入三联药物的研究现状及展望[J]. 中国药事,2021,35(10):1173-1180. 

[6] 游一中. 用于压力定量吸入气雾剂的AerosphereTM创新共悬浮递送技术[J]. 中华结核和呼吸杂志,2019, 42(6): 477-480. 

[7] 梁可克,王志旺,黄柯婷,等. PI3K-AKT信号通路调控慢阻肺气道重塑及中药干预作用研究新进展[J]. 中药药理与临床,2024,40(5):103-108. 

[8] 郑楠,管涛. 电视胸腔镜双侧肺减容术治疗慢性阻塞性肺气肿的并发症发生率及效果观察[J]. 智慧健康,2024, 10(1): 49-52.

引用本文

李欣, 慢阻肺治疗最新进展分析[J]. 国际临床研究杂志, 2024; 8: (12) : 193-195.